PortfoliosLab logoPortfoliosLab logo
NHC vs. NVDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NHC vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in National HealthCare Corporation (NHC) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NHC achieves a 36.54% return, which is significantly higher than NVDA's 15.15% return. Over the past 10 years, NHC has underperformed NVDA with an annualized return of 14.69%, while NVDA has yielded a comparatively higher 68.84% annualized return.


NHC

1D
1.69%
1M
9.28%
YTD
36.54%
6M
36.58%
1Y
81.64%
3Y*
47.80%
5Y*
23.95%
10Y*
14.69%

NVDA

1D
-3.62%
1M
8.20%
YTD
15.15%
6M
19.59%
1Y
52.10%
3Y*
76.15%
5Y*
65.05%
10Y*
68.84%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NHC vs. NVDA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NHC
National HealthCare Corporation
36.54%30.34%19.05%60.84%-9.42%5.39%-20.66%13.02%32.43%-17.26%
NVDA
NVIDIA Corporation
15.15%38.92%171.25%239.02%-50.26%125.48%122.30%76.94%-30.82%81.99%

Correlation

The correlation between NHC and NVDA is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Jan 25, 1999

0.18

The correlation between NHC and NVDA shifts across timeframes, from 0.02 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NHC:

$2.94B

NVDA:

$5.24T

EPS

NHC:

$7.89

NVDA:

$6.53

PE Ratio

NHC:

23.62

NVDA:

32.91

PEG Ratio

NHC:

0.51

NVDA:

0.18

PS Ratio

NHC:

1.93

NVDA:

20.72

PB Ratio

NHC:

2.70

NVDA:

26.80

Total Revenue (TTM)

NHC:

$1.51B

NVDA:

$253.49B

Gross Profit (TTM)

NHC:

$558.31M

NVDA:

$187.95B

EBITDA (TTM)

NHC:

$204.52M

NVDA:

$192.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NHC vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NHC
NHC Risk / Return Rank: 9292
Overall Rank
NHC Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
NHC Sortino Ratio Rank: 9191
Sortino Ratio Rank
NHC Omega Ratio Rank: 8989
Omega Ratio Rank
NHC Calmar Ratio Rank: 9494
Calmar Ratio Rank
NHC Martin Ratio Rank: 9494
Martin Ratio Rank

NVDA
NVDA Risk / Return Rank: 7878
Overall Rank
NVDA Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 7777
Sortino Ratio Rank
NVDA Omega Ratio Rank: 7373
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7979
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NHC vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NHCNVDADifference
Sharpe ratioReturn per unit of total volatility

+1.04

Sortino ratioReturn per unit of downside risk

+1.27

Omega ratioGain probability vs. loss probability

1.42

1.26

+0.16

Calmar ratioReturn relative to maximum drawdown

6.25

2.59

+3.66

Martin ratioReturn relative to average drawdown

16.76

6.36

+10.40

NHC vs. NVDA - Sharpe Ratio Comparison

The current NHC Sharpe Ratio is 2.57, which is higher than the NVDA Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of NHC and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NHCNVDADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.57

1.53

+1.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.87

1.27

-0.40

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.52

1.39

-0.86

Sharpe Ratio (All Time)

Calculated using the full available price history

0.25

0.63

-0.38

Drawdowns

NHC vs. NVDA - Drawdown Comparison

The maximum NHC drawdown since its inception was -96.33%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for NHC and NVDA.


Loading charts...

Drawdown Indicators


NHCNVDADifference

Max Drawdown

Largest peak-to-trough decline

-96.33%

-89.72%

-6.61%

Max Drawdown (1Y)

Largest decline over 1 year

-13.13%

-20.21%

+7.08%

Max Drawdown (3Y)

Largest decline over 3 years

-33.40%

-36.88%

+3.48%

Max Drawdown (5Y)

Largest decline over 5 years

-33.40%

-66.34%

+32.94%

Max Drawdown (10Y)

Largest decline over 10 years

-35.27%

-66.34%

+31.07%

Current Drawdown

Current decline from peak

-6.55%

-8.90%

+2.35%

Average Drawdown

Average peak-to-trough decline

-26.43%

-36.21%

+9.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.89%

8.21%

-3.32%

Volatility

NHC vs. NVDA - Volatility Comparison

National HealthCare Corporation (NHC) and NVIDIA Corporation (NVDA) have volatilities of 13.02% and 12.53%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NHCNVDADifference

Volatility (1M)

Calculated over the trailing 1-month period

13.02%

12.53%

+0.49%

Volatility (6M)

Calculated over the trailing 6-month period

25.41%

25.54%

-0.13%

Volatility (1Y)

Calculated over the trailing 1-year period

31.93%

34.22%

-2.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.73%

51.69%

-23.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.19%

49.80%

-21.61%

Dividends

NHC vs. NVDA - Dividend Comparison

NHC's dividend yield for the trailing twelve months is around 1.37%, more than NVDA's 0.02% yield.


PositionTTM20252024202320222021202020192018201720162015
NHC
National HealthCare Corporation
1.37%1.85%2.25%2.53%3.80%3.11%3.13%2.38%2.52%3.10%2.31%3.14%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%

Financials

NHC vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between National HealthCare Corporation and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
369.81M
81.62B
(NHC) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items

NHC vs. NVDA - Profitability Comparison

The chart below illustrates the profitability comparison between National HealthCare Corporation and NVIDIA Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
74.9%
Portfolio components
NHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported a gross profit of 0.00 and revenue of 369.81M. Therefore, the gross margin over that period was 0.0%.

NVDA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.

NHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported an operating income of 32.25M and revenue of 369.81M, resulting in an operating margin of 8.7%.

NVDA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.

NHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported a net income of 35.86M and revenue of 369.81M, resulting in a net margin of 9.7%.

NVDA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.


Frequently Asked Questions


NHC and NVDA have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NHC has higher volatility (13.02%) compared to NVDA (12.53%). In terms of maximum drawdown, NHC dropped -96.33% vs NVDA's -89.72%.

NHC currently has the higher Sharpe Ratio (2.57 vs 1.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NHC and NVDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer